北信源(300352.SZ):信源密信已成功部署30餘省重要單位的實際信創環境中
格隆匯3月14日丨北信源(300352.SZ)在投資者關係活動上表示,信源密信的競爭力優勢體現在創始人親自帶隊、產品佈局早投入大、產研團隊穩定、安全性高、創新點多、差異化大、參與國家相關重大標準制定、參加國家重點工程多、國家重點單位標杆性落地項目多、支持複雜網絡跨域交換、支持機密級網絡使用、已成功部署30餘省重要單位的實際信創環境中、產品所獲嘉獎級別最高等,結合北信源在信息安全領域深耕28年的品牌優勢、客户資源和市場認可度,和競爭對手相比具備了較大優勢。我們堅信隨着國家相關重大工程的展開和數字中國建設的推進,信源密信將會成為黨政軍等重要單位移動互聯的基礎設施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.